The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hypofractionated radiation therapy for unresectable/locally recurrent intrahepatic cholangiocarcinoma.
 
Alicia Smart
No Relationships to Disclose
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics; EMD Serono
Research Funding - AstraZeneca (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Natasa Petkovska
No Relationships to Disclose
 
Bridget N. Noe
No Relationships to Disclose
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Sanofi
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Cristina Ferrone
No Relationships to Disclose
 
Kenneth Tanabe
Stock and Other Ownership Interests - Helix 12 Pharmaceuticals
Consulting or Advisory Role - Best Doctors, Inc; Cancer Experts Now; UptoDate
Patents, Royalties, Other Intellectual Property - Patent for use of EGFR inhibitor to inhibit liver fibrogenesis and prevent hepatocellular carcinoma; Patent on use of EGF SNP to identify patients at risk for hepatocellular carcinoma
 
Jill N. Allen
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
Motaz Qadan
No Relationships to Disclose
 
Janet E. Murphy
No Relationships to Disclose
 
Lipika Goyal
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Jennifer Yon-Li Wo
No Relationships to Disclose